Clearside Biomedical, Inc. (CLSD)
Q2 2020 Earnings Conference Call
August 10, 2020 04:30 PM ET
Company Participants
Jenny Kobin - Head, Investor Relations
George Lasezkay - President & Chief Executive Officer
Thomas Ciulla - Chief Medical Officer & Chief Development Officer
Charles Deignan - Chief Financial Officer
Conference Call Participants
Boris Peaker - Cowen
Jonathan Wolleben - JMP Securities
Zegbeh Jallah - Roth Capital Partners
Presentation
Operator
Good afternoon ladies and gentlemen and welcome to the Clearside Biomedical Second Quarter 2020 Financial Results and Corporate Update Conference Call. At this time, all participants are in